This renewal application requests continued support for an established, successful, multi-disciplinary train program in Digestive Diseases. The overall objective remains to train qualified postdoctoral individuals ( M.D. and/or Ph.D.) for academic careers in the enteric sciences. We will continue an integrated approach Immunology, Biochemistry/Molecular Biology, Pharmacology) departments. Areas available to trainees include intracellular trafficking, absorption, secretion, growth regulation, malignant transformation), phenomena (gene expression, membrane organization, cell death), diseases (functional bowel, pancreatic and chronic liver diseases, cancer), or populations (the Rochester Epidemiology Project). We have expanded the faculty with NIH-funded investigators in clinical (Thibodeau-Pathology; Nair-Endocrinology; Ahlquist, Camilleri, Farrugia, Karnes-Gastroenterology; Paya-Infectious Diseases) and basic (Lipsky, Kaufmann-Pharmacology; Urrutia- Biochemistry/Molecular Biology) departments. We request support for six postdoctoral trainees per year, an increase of one over prior years, to accommodate the expanded training opportunities, the consistent number of qualified applicants (all to be appointed for a minimum of two years) and the overall success of the program (75% of former trainees in the last 10 years have taken full-time academic positions and 66% of these have extramural grant support). We continue to aggressively recruit qualified Ph.D. candidates and representatives of minority groups; since 1986, when Dr. LaRusso became director, 30% of our trainees have been Ph.D.s and 27% have been from minority groups, including women. Since the last renewal, in addition to enlarging the faculty, significantly expanded integrated facilities are available to trainees including a remodeled GI Research Unit, an expanded Clinical Research Center, and a new Outpatient Clinical Research Center to open in 1999. Also, new Mayo- sponsored Research Cores (NMR, mass spectrometry, optical microscopy, transgenic mice) are now available. Finally, major Institutional initiatives in cancer, molecular medicine, xenotransplantation, pediatrics, and health services research will add approximately 20 additional scientists to the Mayo campus providing new opportunities to faculty collaboration and trainee experiences.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007198-28
Application #
6626919
Study Section
Special Emphasis Panel (SRC)
Program Officer
Podskalny, Judith M,
Project Start
1979-01-01
Project End
2003-12-31
Budget Start
2003-01-01
Budget End
2003-12-31
Support Year
28
Fiscal Year
2003
Total Cost
$270,977
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Yang, Ju Dong; Addissie, Benyam D; Mara, Kristin C et al. (2018) GALAD Score for Hepatocellular Carcinoma Detection in Comparison to Liver Ultrasound and Proposal of GALADUS Score. Cancer Epidemiol Biomarkers Prev :
Yang, Ju Dong; Mannalithara, Ajitha; Piscitello, Andrew J et al. (2018) Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis. Hepatology 68:78-88
Robinson, Matthew M; Dasari, Surendra; Konopka, Adam R et al. (2017) Enhanced Protein Translation Underlies Improved Metabolic and Physical Adaptations to Different Exercise Training Modes in Young and Old Humans. Cell Metab 25:581-592
Tabibian, James H; Gossard, Andrea; El-Youssef, Mounif et al. (2017) Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis. Am J Ther 24:e56-e63
Hicks, S B; Tabibian, J H (2017) Molecular Adsorbent Recirculating System as a Diagnostic and Therapeutic Modality. J Mol Genet Med 11:
Yang, Ju Dong; Dai, Jianliang; Singal, Amit G et al. (2017) Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase. Cancer Epidemiol Biomarkers Prev 26:1085-1092
Wang, Ruisi; Ding, Qian; De Assuncao, Thiago M et al. (2017) Hepatic Stellate Cell Selective Disruption of Dynamin-2 GTPase Increases Murine Fibrogenesis through Up-Regulation of Sphingosine-1 Phosphate-Induced Cell Migration. Am J Pathol 187:134-145
Maiers, Jessica L; Kostallari, Enis; Mushref, Malek et al. (2017) The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice. Hepatology 65:983-998
Yang, Ju Dong; Altekruse, Sean F; Nguyen, Mindie H et al. (2017) Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States. Cancer 123:81-89
Yang, Ju Dong; Ahmed Mohammed, Hager; Harmsen, William S et al. (2017) Recent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota: A US Population-based Study. J Clin Gastroenterol 51:742-748

Showing the most recent 10 out of 150 publications